Ovarian cancer drug could target gene fault in brain tumours

Anne Li                                 2/3/17


A genetic flaw that’s often found in a type of brain tumour may stop the cells from fixing damage to their DNA, findings from a new US study suggest. Researchers at Yale found that this weakness caused brain tumour cells in the lab to become highly sensitive to a drug that’s used to treat some women with ovarian cancer. According to senior author Dr Ranjit Bindra, the discovery – if confirmed in clinical trials – could have “practice-changing implications” as it suggests a possible new approach to treating certain brain tumours.


See original article at: http://www.cancerresearchuk.org/about-us/cancer-news/news-report/2017-02-01-ovarian-cancer-drug-could-target-gene-fault-in-brain-tumours


Post a comment